Eli Lilly (LLY) Net Income - Minority (2009 - 2015)

Eli Lilly (LLY) reported Net Income - Minority of -$19.0 million for Q4 2015, down 27.52% on a YoY basis from -$26.2 million in Q4 2014, and down 27.52% quarter-over-quarter from -$14.9 million in Q4 2014.

Eli Lilly (LLY) Net Income - Minority (2009 - 2015) Analysis & Trends

Eli Lilly has reported Net Income - Minority for 6 years, with the latest figure at -$19.0 million in Q4 2015.

  • For the quarter ending Q4 2015, Net Income - Minority fell 27.52% year-over-year to -$19.0 million; the trailing twelve-month figure through Dec 2015 stood at -$19.0 million (down 27.52% YoY), and the FY2015 full-year result was -$19.0 million, down 27.52% from the prior year.
  • Net Income - Minority for Q4 2015 stood at -$19.0 million, down from -$14.9 million in the prior quarter.
  • The five-year high for Net Income - Minority was $6.1 million in Q4 2011, with the low at -$19.0 million in Q4 2015.
  • Historically, Net Income - Minority has averaged -$9.2 million across 5 years, with a median of -$9.3 million in 2013.
  • Annual changes were most pronounced in 2012 — Net Income - Minority plunged 242.62% — and 2013, when it declined 6.9%.
  • Eli Lilly's Net Income - Minority stood at $6.1 million in 2011, then sank by 242.62% to -$8.7 million in 2012, then declined by 6.9% to -$9.3 million in 2013, then plunged by 60.22% to -$14.9 million in 2014, then slipped by 27.52% to -$19.0 million in 2015.
  • The last three Net Income - Minority figures came in at -$19.0 million (Q4 2015), -$14.9 million (Q4 2014), and -$9.3 million (Q4 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn -
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn -
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn -
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn -
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn -
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2015 -19.00 Mn
Dec 31, 2014 -14.90 Mn
Dec 31, 2013 -9.30 Mn
Dec 31, 2012 -8.70 Mn
Dec 31, 2011 6.10 Mn
Sep 30, 2009 -400,000.00